ecoinvent v3.13, planned for release in 2026, expands both the coverage and the timeliness of our datasets. It also marks a first for the database, with pharmaceuticals added as a new sector.
The OECD estimates that pharmaceuticals and medical goods account for about one-quarter of healthcare-related greenhouse gas emissions. This means decarbonizing pharma is fundamental for a sustainable healthcare industry. Yet, the pharma data gap is especially pronounced, with generic chemical data too far removed from the sector’s operating reality.
In collaboration with the Pharma LCA Consortium, ecoinvent v3.13 will introduce regionalized, PAS 2090 Product Category Rule (PCR) compliant pharmaceutical datasets to begin to fill this gap—making results more accurate, verifiable, and comparable. These datasets cover core building blocks, operational and process elements, circular solvent management, life cycle and waste management, and regionalized pharmaceutical supply chains.
It’s a first step toward closing a data gap the industry has long flagged.